Prevention of malaria during pregnancy: intermittent preventive treatment with two versus three doses of sulfadoxine-pyrimethamine
Completed
- Conditions
- Malaria during pregnancyInfections and InfestationsPlasmodium falciparum malaria
- Registration Number
- ISRCTN74189211
- Lead Sponsor
- ational Direction of Health (Mali)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 812
Inclusion Criteria
1. Aged 14 to 45 years, female pregnant women
2. Gestational age between 16 and 24 weeks
3. Provide consent form
4. Not having chronic disease
5. Willing to terminate the study and follow study conditions
Exclusion Criteria
Does not meet inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method